Literature DB >> 30333292

Echocardiography-guided percutaneous closure of patent ductus arteriosus without arterial access: Feasibility and safety for a new strategy.

Weizhi Zhang1, Lei Gao1, Wancun Jin1, Qin Wu1, Shijun Hu1, Yifeng Yang1, Tianli Zhao1.   

Abstract

OBJECTIVE: To evaluate the feasibility and safety of device closure of patent ductus arteriosus (PDA) using only venous access under echocardiography guidance alone.

Methods: A total of 102 consecutive pediatric patients underwent transcatheter PDA closure without arterial access, under the guidance of only echocardiography. The patients were followed up by clinical examination, electrocardiogram, and echocardiogram at 1, 3, 6 12, and 24 months.

Results: Transvenous PDA closure under echocardiographic guidance was successful in 99 (97.1%) patients. There were no acute procedural complications or severe adverse events. The duration ranged from 10 to 65 minutes (median, 21 minutes). Immediate complete closure of PDA was achieved in 87 patients (87.9%), and 100% of the patients were completely closed after 24 h. There were no severe adverse events in the period of 1-24 months (median, 12 months) follow up.

Conclusion: Transvenous PDA closure without fluoroscopy avoids radiation exposure, contrast agent usage and potential arterial complications. It can be used as an alternative procedure, especially for children.

Entities:  

Mesh:

Year:  2018        PMID: 30333292     DOI: 10.11817/j.issn.1672-7347.2018.09.011

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  1 in total

1.  Echocardiography-Guided Percutaneous Patent Ductus Arteriosus Closure: 1-Year Single Center Experience in Indonesia.

Authors:  Sisca Natalia Siagian; Radityo Prakoso; Bayushi Eka Putra; Yovi Kurniawati; Olfi Lelya; Aditya Agita Sembiring; Indriwanto Sakidjan Atmosudigdo; Poppy Surwianti Roebiono; Anna Ulfah Rahajoe; Ganesja Moelia Harimurti; Brian Mendel; Christianto Christianto; Moira Setiawan; Oktavia Lilyasari
Journal:  Front Cardiovasc Med       Date:  2022-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.